Nacon S.a. buy krebskrebs
Start price
21.03.23
/
50%
€2.06
Target price
21.03.24
€3.00
Performance (%)
-43.36%
End price
22.03.24
€1.16
Summary
This prediction ended on 22.03.24 with a price of €1.16. Massive losses of -43.36% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Nacon S.a. | - | - | - | - |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% | 53.202% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% | 91.095% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% | 63.933% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% | 64.840% |
Comments by krebskrebs for this prediction
In the thread Nacon S.a. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Nacon S.a.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

